AMGN vs UVSP · P/E 24, rev $10.05B vs P/E 12, rev $171.8M
Amgen Inc (AMGN) versus Univest Corporation Pennsylvania (UVSP) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Univest Corporation Pennsylvania (UVSP) is a banks - regional company listed on NASDAQ.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported UVSP revenue for 2026-06-30 was $171.8M. Net income was $50.0M. Revenue was up 96.5% from 2026-03-31 to 2026-06-30. UVSP currently screens at market cap $1.15B and trailing P/E 12.5.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. UVSP currently screens at market cap $1.15B and trailing P/E 12.5.
Not investment advice. Open the AMGN and UVSP stock pages for the full models.
Not investment advice.